These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32685316)

  • 1. Pulmonary Manifestations in Systemic Sclerosis: Hospital-Based Descriptive Study.
    Mulkoju R; Saka VK; Rajaram M; Kumari R; Negi VS; Mohanty Mohapatra M; Govindaraj V; Dwivedi DP; Mahesh Babu V
    Cureus; 2020 Jun; 12(6):e8649. PubMed ID: 32685316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on pulmonary complications of systemic sclerosis in eastern India.
    Ghosh A; Banerjee A; Biswas AK
    Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
    Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters.
    Abdelati AA; Deghady AA; Abdelhady AM; Bastawy RA; Shaaban A
    Curr Rheumatol Rev; 2023; 19(2):189-196. PubMed ID: 35984025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HRCT in systemic sclerosis: correlation between respiratory functional indexes and extension of lung failure.
    Gatta G; Di Grezia G; Iacomino A; Russo A; Petrillo M; Feragalli B; Cappabianca S; Grassi R
    J Biol Regul Homeost Agents; 2013; 27(2):579-87. PubMed ID: 23830407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma-overlap syndromes: capillaroscopy, laboratory, and clinical manifestations and follow-up compared to scleroderma patients.
    Shenavandeh S; Azariyon Z; Nazarinia MA
    Reumatologia; 2023; 61(6):448-459. PubMed ID: 38322100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis.
    Shenavandeh S; Haghighi MY; Nazarinia MA
    Reumatologia; 2017; 55(1):15-23. PubMed ID: 28386138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
    Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nailfold Capillaroscopic Changes as a Marker of Interstitial Lung Disease in Systemic Sclerosis: A Cross-Sectional Study in a Tertiary Care Hospital in Eastern India.
    Rudra O; Baisya S; Mallick S; Chatterjee G
    Indian Dermatol Online J; 2022; 13(2):216-220. PubMed ID: 35287403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway resistance and reactance are affected in systemic sclerosis.
    Aronsson D; Hesselstrand R; Bozovic G; Wuttge DM; Tufvesson E
    Eur Clin Respir J; 2015; 2():28667. PubMed ID: 26672963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients.
    Ruaro B; Confalonieri M; Salton F; Wade B; Baratella E; Geri P; Confalonieri P; Kodric M; Biolo M; Bruni C
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33922710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
    Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
    Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung involvement in systemic sclerosis].
    Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
    Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.
    Patiwetwitoon S; Wangkaew S; Euathrongchit J; Kasitanon N; Louthrenoo W
    J Clin Rheumatol; 2012 Aug; 18(5):229-33. PubMed ID: 22832288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.